Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dowson

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Drugs in R&D|May 7, 2008
Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice settingAndrew J Dowson, Shaun G Kilminster, Rebecca Salt
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 6, 2007
Experience gained by basic surgical trainees in varicose vein surgery over a 15 year period - has it changed?C J Dowson, B Levy, C R R Corbett
American Journal of Respiratory and Critical Care Medicine|December 6, 2001
Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with declineL J Dowson, P J Guest, R A Stockley
Acta Psychiatrica Scandinavica|October 1, 1985
Psychiatric morbidity following total and partial thyroidectomyG E Berrios, A Leysen, C Samuel, et al.
Chest|October 16, 2002
The relationship of chronic sputum expectoration to physiologic, radiologic, and health status characteristics in alpha(1)-antitrypsin deficiency (PiZ)Lee J Dowson, Peter J Guest, Robert A Stockley
Current Medical Research and Opinion|August 9, 2005
Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraineElizabeth W Loder, Andrew J Dowson, Egilius L H Spierings
Headache|April 28, 2004
Almotriptan improves response rates when treatment is within 1 hour of migraine onsetA J Dowson, H Massiou, J M Lainez, et al.
Pharmacoeconomics|October 13, 2001
The cost effectiveness of stratified care in the management of migraineP Williams, A J Dowson, A M Rapoport, et al.
Cephalalgia : an International Journal of Headache|July 23, 2002
Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trialA J Dowson, H Massiou, J M Laínez, et al.
Current Medical Research and Opinion|December 19, 2002
New guidelines for the management of migraine in primary careA J Dowson, S Lipscombe, J Sender, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Drugs in R&D|May 7, 2008
Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice settingAndrew J Dowson, Shaun G Kilminster, Rebecca Salt
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|November 6, 2007
Experience gained by basic surgical trainees in varicose vein surgery over a 15 year period - has it changed?C J Dowson, B Levy, C R R Corbett
American Journal of Respiratory and Critical Care Medicine|December 6, 2001
Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with declineL J Dowson, P J Guest, R A Stockley
Acta Psychiatrica Scandinavica|October 1, 1985
Psychiatric morbidity following total and partial thyroidectomyG E Berrios, A Leysen, C Samuel, et al.
Chest|October 16, 2002
The relationship of chronic sputum expectoration to physiologic, radiologic, and health status characteristics in alpha(1)-antitrypsin deficiency (PiZ)Lee J Dowson, Peter J Guest, Robert A Stockley
Current Medical Research and Opinion|August 9, 2005
Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraineElizabeth W Loder, Andrew J Dowson, Egilius L H Spierings
Headache|April 28, 2004
Almotriptan improves response rates when treatment is within 1 hour of migraine onsetA J Dowson, H Massiou, J M Lainez, et al.
Pharmacoeconomics|October 13, 2001
The cost effectiveness of stratified care in the management of migraineP Williams, A J Dowson, A M Rapoport, et al.
Cephalalgia : an International Journal of Headache|July 23, 2002
Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trialA J Dowson, H Massiou, J M Laínez, et al.
Current Medical Research and Opinion|December 19, 2002
New guidelines for the management of migraine in primary careA J Dowson, S Lipscombe, J Sender, et al.
Pageof 7